Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
866323-14-0
Purity
95%
Belinostat is a novel agent that inhibits the enzyme histone deacetylase with a sulfonamide-hydroxamide structure. It is used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Properties
Name
Belinostat
Smiles
ONC(=O)/C=C/C=1C=CC=C(C1)S(=O)(=O)NC=2C=CC=CC2
Targets
Please log in to see this information
SDS
(2E)-3-[3-(anilinosulfonyl)phenyl]-N-hydroxy-acrylamide | (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide | (E)-N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)acrylamide | Beleodaq | PDX-101 | PX105684 | PXD-101 | belinostat
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$68
2 mg
$72
5 mg
$80
10 mg
$103
15 mg
$118
20 mg
$132
25 mg
$144
30 mg
$152
35 mg
$167
40 mg
$186
45 mg
$198
50 mg
$212
75 mg
$306
100 mg
$POA
Quantity
1
Total amount
$ 80
(2E)-3-[3-(anilinosulfonyl)phenyl]-N-hydroxy-acrylamide | (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide | (E)-N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)acrylamide | Beleodaq | PDX-101 | PX105684 | PXD-101 | belinostat
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.